Evaluation of serum (1 → 3)-β-d-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors

Purpose We investigated the clinical performance of (1 → 3)-β- d -glucan (BG), as an early marker of invasive fungal infections (IFI), in different clinical settings. Methods BG serum levels were assessed by Fungitell (Associates of Cape Cod, Inc), in parallel with galactomannan (GM) when requested...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Infection 2016-04, Vol.44 (2), p.223-233
Hauptverfasser:	Pini, P., Bettua, C., Orsi, C. F., Venturelli, C., Forghieri, F., Bigliardi, S., Faglioni, L., Luppi, F., Serio, L., Codeluppi, M., Luppi, M., Mussini, C., Girardis, M., Blasi, Elisabetta
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antigens, Fungal - blood beta-Glucans - blood Family Medicine Female Fungemia - diagnosis General Practice Humans Infectious Diseases Internal Medicine Male Mannans - blood Medicine Medicine & Public Health Middle Aged Original Paper Predictive Value of Tests Prospective Studies Sensitivity and Specificity Serum - chemistry Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!